Yoshihide Ueda

19PUBLICATIONS
90CO-AUTHORS
Public transportCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 15, 2026
Time Matters More Than Distance: The Impact of Transport Logistics on Total Ischemic Time and Survival After Deceased-Donor Liver Transplantation.

|Jul 20, 2026
Baseline DCP May Modify Response to Atezolizumab-Bevacizumab Versus Durvalumab-Tremelimumab in Unresectable HCC.

|Jul 16, 2026
Simplified BALAD (BALAD-S) Score as a Guide for First-Line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma.

|May 23, 2026
Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial.

|May 11, 2026
Ablation-Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma.

|May 02, 2026
ALDH2 Polymorphism in Alcohol-Related Cirrhosis Requiring Liver Transplantation: A Recipient-Donor Analysis.

Pageof 4

Frequent Collaborators

10 joint publications

Toshifumi Tada

9 joint publications

Kunihiko Tsuji

9 joint publications

Fujimasa Tada

9 joint publications

Kazunari Tanaka